Podd: The Biotech Startups Podcast

🧬 Non-Traditional Leadership & Knowledge Sharing: The New Edge in Biotech | Aaron Edwards (Part 3/4)

23 juli | 40 min

🧬 Why Most Biotech Startups Fail (And How to Survive Market Crashes) | Aaron Edwards (Part 2/4)

16 juli | 46 min

🧬 Embracing Identity & Curiosity: Being Different Fuels Innovation | Aaron Edwards (Part 1/4)

9 juli | 49 min

🧬 Growth Without Venture Capital: The Bootstrapped Bioscience Playbook | Ivan Liachko (Part 4/4)

2 juli | 37 min

🧬 How 3D Genome Mapping is Changing Everything We Know About DNA | Ivan Liachko (Part 3/4)

25 juni | 36 min

🧬 Startup Survival Skills: Resilience, Frugality & Real Talk in Biotech | Ivan Liachko (Part 2/4)

18 juni | 31 min

🧬 Passion Is Chaos: Grit, Curiosity, & the Biotech Breakthrough Mindset | Ivan Liachko (Part 1/4)

9 juni | 36 min

🧬 AI, Mentors & the Future of Biotech: Teambuilding, Investing, & Innovation | Johnny Hu (Part 4/4)

5 juni | 39 min

🧬 Biotech Investing Unlocked: Mindset Shift, Risk, and Founder-First Lessons | Johnny Hu (Part 3/4)

2 juni | 37 min

🧬 The Shelf Life of Innovation: CRISPR, Biotech Culture & Winning Teams | Johnny Hu (Part 2/4)

29 maj | 38 min

🧬 NASA, Harvard & Biotech: A Journey to Investing at Menlo Ventures | Johnny Hu (Part 1/4)

26 maj | 44 min

🧬 Simulating Life & Accelerating Discovery: Deep Origin’s Biotech Vision | Michael Antonov (Part 4/4)

22 maj | 45 min

🧬 Debugging Aging: How a VR Pioneer is Revolutionizing Longevity | Michael Antonov (Part 3/4)

19 maj | 28 min

🧬 Building Oculus: Innovation, Grit & the $2 Billion VR Revolution | Michael Antonov (Part 2/4)

15 maj | 36 min

🧬 The Borrowed Computer That Built Oculus - An Unlikely Biotech Journey | Michael Antonov (Part 1/4)

12 maj | 42 min

🧬 The Secret to Biotech Success: Time, Tools & Teamwork | Bogdan Knezevic (Part 4/4)

8 maj | 44 min

🧬 Purpose-Driven Innovation: Building Teams to Solve Biotech Problems | Bogdan Knezevic (Part 3/4)

5 maj | 36 min

🧬 Letting Go to Level Up: Oxford, Identity, & Tenacity in Biotech | Bogdan Knezevic (Part 2/4)

1 maj | 34 min

🧬Immigrant Grit & Athletic Discipline: Building a Biotech Legacy | Bogdan Knezevic (Part 1/4)

28 april | 44 min

🧬 Redefining Biotech: Building Enduring Value Beyond Acquisition | Rabia Khan (Part 4/4)

24 april | 48 min

🧬 Sales Skills & Resilience: Hidden Drivers of Biotech Success | Rabia Khan (Part 3/4)

21 april | 38 min

🧬 Rabia Khan - Serna Bio: Bridging Science & Tech—PhDs, MBAs, & Biotech Innovation (Part 2/4)

17 april | 45 min

🧬 Rabia Khan - Serna Bio: Unraveling the Genetics of AI-Driven Drug Discovery (Part 1/4)

14 april | 48 min

🧬Alfredo Andere - LatchBio: Revolutionizing Biopharma Data & Mastering Enterprise Sales (Part 4/4)

10 april | 49 min

🧬Alfredo Andere - LatchBio: Building Biotech Data Tools to Revolutionize Life Sciences (Part 3/4)

7 april | 31 min

🧬Alfredo Andere - LatchBio: College Friends, Biotech Beginnings & Thoughtful Persistence (Part 2/4)

3 april | 34 min

🧬 Alfredo Andere - LatchBio: Conquering Berkeley's EECS & Building a Global Vision (Part 1)

31 mars | 38 min

🧬 Michael Paliotti - MilliporeSigma: Master Biotech Sales & Build High-Performance Teams (Part 4/4)

27 mars | 30 min

🧬 Michael Paliotti: Blending Science, Sales, and Side Hustles in Biotech (Part 3/4)

24 mars | 41 min

🧬 Michael Paliotti: Navigating Biotech Careers & Building Lasting Relationships (Part 2/4)

20 mars | 43 min

🧬 Michael Paliotti: Navigating a Winding Path to Biotech Success (Part 1/4)

17 mars | 40 min

🧬 Stavros Papadopoulos: Transforming Data Management (Part 4/4)

13 mars | 33 min

🧬 Stavros Papadopoulos: Scaling TileDB & Revolutionizing Data Infrastructure (Part 3/4)

10 mars | 35 min

🧬Stavros Papadopoulos: How Serendipity Sparked TileDB's Startup Journey (Part 2/4)

6 mars | 42 min

🧬 Stavros Papadopoulos: A Journey in Computer Science & Data Management (Part 1/4)

3 mars | 54 min

🧬 Becky Beattie: Scaling LaunchBio & Democratizing Biotech Entrepreneurship (Part 2/2)

27 februari | 66 min

🧬 Becky Beattie: From Rural Beginnings to Building a National Biotech Network (Part 1)

24 februari | 63 min

🧬 Dr. Kate Yen: Scaling a Biotech, Running Lean, & Utilizing Translational Biology (Part 2)

20 februari | 52 min

🧬 Kate Yen - Part 1 | From Academia to Biotech Leader | Translating Research into Cancer Therapies | Early Days at Merck & Agios

17 februari | 52 min

🧬 Oguzhan Atay - Part 2 | From Immigrant to Biotech Innovator | Battling Deportation with Nobel Laureate Support | Building a $140M Prenatal Testing Empire

13 februari | 65 min

🧬 Oguzhan Atay - Part 1 | From Small-Town Turkey to Stanford PhD | Solving Cell Cycle Mysteries | Building a Biotech During a Global Pandemic

10 februari | 61 min

🧬 Parag Shah - Part 2 | Scaling a Multi-Billion Dollar Life Sciences Fund | Culture, Capital & Entrepreneurship | The K2 HealthVentures Story

6 februari | 64 min

🧬 Parag Shah - Part 1 | Rethinking Biotech Startup Funding | Building Smarter Capital Strategies | Risk, Reward & Leadership in Investing

3 februari | 47 min

🧬 Jason C. Foster - Part 2 | Manufacturing Brighter Futures | From Richmond to London: Building a Biotech Empire | Culture Eats Strategy for Breakfast

30 januari | 65 min

🧬 Jason C. Foster - Part 1 | From Paper Routes to Pharma | Navigating the Dot-Com Bubble | Building a $1B Addiction Medicine Business in 4 Years

27 januari | 56 min

🧬 Rafael Rosengarten - Part 4 | Lessons in Scaling a Biotech Startup | Using AI to Transform Cancer Diagnostics | The Genialis Supermodel & krasID

23 januari | 41 min

🧬 Rafael Rosengarten - Part 3 | Leveraging AI in Precision Medicine | How Predictive Biomarkers Transform Oncology | Lessons from Scaling a Startup

20 januari | 32 min

🧬 Rafael Rosengarten - Part 2 | From Marine Biology to Synthetic Biology | Building Biofuel Tools at JBEI | When Academic Labs Embrace Entrepreneurship

16 januari | 35 min

🧬 Rafael Rosengarten - Part 1 | From Salt Marsh to Biotech CEO | Snorkeling into Science | Choosing Marine Biology Over Cooking on a Mediterranean Yacht

13 januari | 31 min

🧬 Cyriac Roeding - Part 4 | Revolutionizing Cancer Detection & Therapy | Harnessing Synthetic Biology to Reshape Diagnostics | Solving Biotech’s Toughest Problems

9 januari | 38 min

🧬Cyriac Roeding - Part 3 | Founding Shopkick During the 2008 Financial Crisis | Transforming Retail with Mobile Tech | Exploring AI’s Use in Clinical Trials & Reshaping Drug Development

6 januari | 32 min

🧬 Cyriac Roeding - Part 2 | From Digital Clocks to Global Mobile Marketing | Cracking Coca-Cola's 160 Million Bottle Code | Silicon Valley's Pine-Scented Entrepreneurship | Leapfrogging Technology in the Amazon Jungle

2 januari | 31 min

🧬 Cyriac Roeding - Part 1 | From Flea Market Entrepreneur to Silicon Valley CEO | Reinvention During an Exchange Year | Finding Perspective in Japanese Business Culture

30 december 2024 | 37 min

🧬 Kate Neville - Part 4 | Balancing IP Enforcement & Licensing | Leveraging Shelved Pharma Assets | Building Resilient IP Portfolios

19 december 2024 | 32 min

🧬Kate Neville - Part 3 | Fundamentals of IP Strategy for Biotechs | Safeguarding Discoveries & Technology | Aligning Science with Patents | Navigating Global Patent Considerations

16 december 2024 | 30 min

🧬Kate Neville - Part 2 | Navigating Law School as a Scientist | From Patent Agent to Lawyer | Thriving at the Intersection of Science & Law | Continuous Learning in Diverse Scientific Fields

12 december 2024 | 21 min

🧬 Kate Neville - Part 1 | From Youngest of Six to Patent Law Pioneer | When Chemistry Sets Spark Scientific Careers | Leading Through Autonomy | Serendipitous Path from Lab Bench to IP Law

9 december 2024 | 28 min

🧬 Barry Ticho - Part 4 | Founding Verve Therapeutics Over Breakfast | Gene Editing for Cardiovascular Disease | Leadership Lessons From a First-Time Founder | Stoke’s Vision for RNA-Based Medicines

5 december 2024 | 40 min

🧬 Barry Ticho - Part 3 | Lessons From Rigorous Drug Development | Industry vs. Academic Research Standards | A Patient-Centered Approach to Clinical Trials | How RNA is Shaping Modern Medicine

2 december 2024 | 37 min

🧬Barry Ticho - Part 2 | Zebrafish Hearts & Pediatric Cardiology | Balancing Lab Work & Clinical Practice | Navigating Academic Medicine's Challenges | The Draw of Biopharma & Translational Medicine

28 november 2024 | 28 min

🧬Barry Ticho - Stoke Therapeutics - Part 1 | From Family of Physicians to Vision-Driven Scientist | Barry’s MD-PhD Journey | Leadership Through Critical Thinking & Resilience | The Journey From Academia to Industry

25 november 2024 | 37 min

🧬Chris Moxham - Transcripta Bio - Part 4 | Partnership Strategies with Big Pharma | Balancing Science & Business | Leveraging AI in Drug Discovery | The Vision for Transcripta Bio

21 november 2024 | 27 min

🧬Chris Moxham - Transcripta Bio - Part 3 | Embracing the Startup Challenge | Mastering Science-to-Business Communication | Building a Scalable Discovery Engine | Leveraging AI & Genetics in Drug Development

18 november 2024 | 26 min

🧬Chris Moxham - Transcripta Bio - Part 2 | From Eli Lilly Recruit to NYC Lab Builder | Leading High-Stakes Drug Discovery | Pioneering Quantitative Biology | "Making the Trains Run on Time"

14 november 2024 | 30 min

🧬Chris Moxham - Transcripta Bio - Part 1 | From Long Island to Biotech Pioneer | Cornell's Pivotal Role in Research Passion | Strategic Leap to Pharma Industry | Cultivating Effective Leadership in Science

11 november 2024 | 32 min

🧬Michael Chen - Nuclera - Part 2 | From Grad Student to Biotech CEO | Unique Challenges Combining Science & Business | Developing Breakthrough Products | Building Partnerships with Big Pharma | Creating a Biotech GTM Strategy

7 november 2024 | 65 min

🧬Michael Chen - Nuclera - Part 1 | Influence of a Data-Driven Family | Do the Dishes in a Lab | NIH-Oxford Cambridge Scholarship Program | What Got Us Here Won’t Get Us There

4 november 2024 | 53 min

🧬 Neela Patel - Bonum Therapeutics - Part 4 | Transitioning to Seattle Genetics & Business Development | Insights from Roche’s Acquisition | Building a Transformative Oncology Pipeline with Bonum Therapeutics

31 oktober 2024 | 33 min

🧬 Neela Patel - Bonum Therapeutics - Part 3 | Developing Pipeline Strategy at Poniard Pharmaceuticals | Business & Corporate Development in Oncology | Transitioning from Abbott to AbbVie to Seagen

28 oktober 2024 | 40 min

🧬Neela Patel - Bonum Therapeutics - Part 2 | Leading an Academic Microbiology Lab | The Value of Personal Relationships in the Workplace | Leading a Team & Learning on the Job | The Volatility of an Acquisition

24 oktober 2024 | 38 min

🧬 Neela Patel - Bonum Therapeutics - Part 1 | Growing Up in an Intellectual Household | How One Biology Class Inspired Her | Working With Influential Scientists at DNAX | Pursuing the Intersection of Science & Business

21 oktober 2024 | 41 min

🧬eMalick Njie, Ph.D - Ecotone - Part 4 | Building Ecotone AI to Cure Rare Diseases | Diffusion Transformers in Genomics | Synthetic Genomes for AI Training | Long-Term Vision for Genetic Breakthroughs

17 oktober 2024 | 31 min

🧬 eMalick Njie, Ph.D - Ecotone - Part 3 | Founding an AI-Powered Biotech | Overcoming Challenges & Personal Sacrifices | Importance of Team Alignment | Combining AI, Genetics, & Population Studies

14 oktober 2024 | 53 min

🧬eMalick Njie, Ph.D - Ecotone - Part 2 | What is Memory? | Playing “Stump the Professor” | Lab Coat Labs vs Sandals Labs | Wanting to Help People at Scale

10 oktober 2024 | 55 min

🧬eMalick Njie, Ph.D - Ecotone - Part 1 | Growing Up in the Gambia | The Unending Book of Neuroscience | Being a Professional Scientist | How to Lose Your MIT Recommendation Letter: 101

7 oktober 2024 | 38 min

🧬Barbara Alcaraz Silva - J.P. Morgan - Part 4 | Barbara’s Pivot into Banking | The Power of Mentorship & Resilience | Seizing Unexpected Opportunities | The Challenges of Building a Career in Science & Finance

3 oktober 2024 | 39 min

🧬 Barbara Alcaraz Silva - J.P. Morgan - Part 3 | From Academia to Entrepreneurship, Investing, & Advising | Co-Founding a Startup | Challenges of Early-Stage Company Building | Improve Your Investor Pitch & Connect with the Right People

30 september 2024 | 35 min

🧬 Barbara Alcaraz Silva - J.P. Morgan - Part 2 | Mentorship & Research at the Beckman Laser Institute | An Entrepreneurial PhD Experience | Exploring Stem Cell Biology in London | Navigating Networking & Postdoc Opportunities

26 september 2024 | 28 min

🧬 Barbara Alcaraz Silva - J.P. Morgan - Part 1 | Living the American Dream & Emigrating From Mexico | Soaking Up Experiences & Embracing Opportunities | Researching at the Harvard of Mexico | Presenting In Spanish at a National Conference

23 september 2024 | 38 min

🧬 Derek Hennecke - Kincell Bio - Part 4 | Building & Scaling Xcelience | Buy-Side vs. Sell-Side of M&A | The Importance of Continuous Learning | Transition into Investing & Board Member Work

19 september 2024 | 32 min

🧬 Derek Hennecke - Kincell Bio - Part 3 | Starting an Operations Role in Egypt | The Importance of Teamwork | Moving into Biologics & Overseeing GMP Operations | Buying a Business & Founding Xcelience

16 september 2024 | 39 min

🧬 Derek Hennecke - Kincell Bio - Part 2 | Taking Risks and Jumping for the Right Opportunity | The Willingness To Do, Opens Doors | Your Job is More than the Products It is Producing | Building Trust in Other Countries

12 september 2024 | 32 min

🧬 Derek Hennecke - Kincell Bio - Part 1 | Sales Means Having Two Ears and One Mouth | The Support of a Partner Can Make or Break a Career | Skip the MBA

9 september 2024 | 31 min

🧬 Doug Drysdale - Cybin - Part 4 | The Challenges of Running a Public Company | Transforming Psychiatric Treatments Through Psychedelic Compounds | Developing Breakthrough Therapies in Depression & Anxiety

5 september 2024 | 28 min

🧬 Doug Drysdale - Cybin - Part 3 | Jumping from BD to M&A | Leveraging Debt for Strategic Acquisitions | The Importance of Cultural Fit in Successful Deals | Making an Impact at Norwich, Alvogen, & Pernix Therapeutics

2 september 2024 | 28 min

🧬 Doug Drysdale - Cybin - Part 2 | Deals Only Get Done in Person | Learning Financing Through a Company’s Hardship | Bureaucracy in the Workplace | How to Educate Yourself to Determine Good Licensing Deals

29 augusti 2024 | 31 min

🧬 Doug Drysdale - Cybin - Part 1 | One Teacher Can Change Your Whole Perspective | The Forefront of the Human Genome Project | How Loss Taught Him Not to Take Life For Granted | Learning How to Be Personable in Sales

26 augusti 2024 | 31 min

🧬 Noam Solomon - Immunai - Part 4 | How Searching for Investors is Like Finding a Life Partner | Luck In Fundraising | The Optimal Features of the Immune System | The Advice to Take More Risks

22 augusti 2024 | 27 min

🧬 Noam Solomon - Immunai - Part 3 | Deciphering the Book That is the Human Immune System | Building Immunai’s Team | The Importance of Single Cell Multi-Omics | Big Pharma & Dancing With Gorillas

19 augusti 2024 | 34 min

🧬 Noam Solomon - Immunai - Part 2 | The Value of Attending Prestigious Institutions | Immunai’s Genesis | AI, Machine Learning, & Their Applications in the Life Sciences | Mapping the Human Immune System

15 augusti 2024 | 26 min

🧬 Noam Solomon - Immunai - Part 1 | Attending Undergrad at 14 Year Old | How Mathematics Can Make You a Lone Wolf | The Difference Between Noam’s Two PhDs | The Resilience Required for Entrepreneurship

12 augusti 2024 | 32 min

🧬 Shekhar Mitra - InnoPreneur & P&G - Part 4 | Finding Foundational Intrapreneurship at P&G | Early Innovation in Drug Discovery & Development | Community & Diversity Leadership in Arts & STEM

8 augusti 2024 | 42 min

🧬 Shekhar Mitra - InnoPreneur & P&G - Part 3 | The First Big Innovation Center in Asia | The Whole Work of Leadership | Noticeability Driven Through Technology | Developing Emotional Drivers

5 augusti 2024 | 35 min

🧬 Shekhar Mitra - InnoPreneur & P&G - Part 2 | Columbia & Yale: Collaborating with Top Physicists | Moving from Academia to Procter & Gamble | Navigating Challenges, Celebrating Successes | Leading Clinical Trials & Working with the FDA

1 augusti 2024 | 52 min

🧬 Shekhar Mitra - InnoPreneur & P&G - Part 1 | Growing Up in a Multigenerational Household | Undergraduate Experience at IIT | Groundbreaking Lab Research at Columbia | Diverse Experiences in New York City

29 juli 2024 | 44 min

🧬 Nathan Clark - Ganymede - Part 4 | Data Integration & Automation in the Life Sciences | Building a Technical Team & Go-To-Market Motion | Creating Efficient Data Infrastructures | Automating Complex Workflows

25 juli 2024 | 36 min

🧬 Nathan Clark - Ganymede - Part 3 | Parallels Between Benchling & Salesforce | Getting Customers to Fully Buy-In | Managing the “Writhing Snake of Data” | Ganymede Achieves Escape Velocity Growth

22 juli 2024 | 30 min

🧬 Nathan Clark - Ganymede - Part 2 | Moving from Goldman Sachs to Fintech | Exploring Product Management at Affirm | Leveraging Data & Building Tech Solutions| Impacting Scientific Progress at Benchling

18 juli 2024 | 28 min

🧬 Nathan Clark - Ganymede - Part 1 | Early Influence of Entrepreneurs | Developing Passions for Both Finance & Life Sciences | Fundamentals of Trading & Finances | Experiences & Opportunities at Goldman Sachs

15 juli 2024 | 37 min

🧬 David Li - Meliora Therapeutics - Part 4 | Mechanism Identification in Biotech | AI & ML in Drug Development | Creating a New Method for Drug Discovery | Fundraising for Meliora | Building a Foundational Startup Team

11 juli 2024 | 28 min

🧬 David Li - Meliora Therapeutics - Part 3 | Developing a Blood-Based Lung Cancer Test | The Rifle-Shot Nature of Biotech | Software Vs. Biotech Product Market Fit | The Super Power all Startups Need

8 juli 2024 | 20 min

🧬 David Li - Meliora Therapeutics - Part 2 | From Finance to Biotech Entrepreneurship | Building Solid Teams & Navigating Market Dynamics | Lessons in Early-Stage Startups

3 juli 2024 | 25 min

🧬 David Li - Meliora Therapeutics - Part 1 | Childhood in China and Kentucky | Early Opportunities in Research & Biology | Benefits of Dual Degrees | Experiences & Opportunities while Investment Banking at Goldman Sachs

1 juli 2024 | 30 min

🧬 Mark Kotter - bit.bio - Part 4 | Democratizing Access to Cells & the Evolution of bit.bio | A Financial Journey from Angel Investment to IPO | Building a Tech Bio Platform & Mark’s 10-Year Vision

27 juni 2024 | 38 min

🧬 Mark Kotter - bit.bio - Part 3 | Success in Academia vs. Industry | Vital Things All Founders Should Know | The Importance of Company Culture | bit.bio & the Operating System of Life

24 juni 2024 | 25 min

🧬 Mark Kotter - bit.bio - Part 2 | Navigating Between the Clinical & Research Worlds | Lessons in Combining Different Fields | The Evolution of Cell Therapies | Transitioning from Academia to Entrepreneurship

20 juni 2024 | 23 min

🧬 Mark Kotter - bit.bio - Part 1 | Childhood Experiences in Different Countries | Overcoming Dyslexia & Developing Math Skills | Pivoting His Career to Science and Medicine | Facilitating Curiosity Via Research & Lab Experiences

17 juni 2024 | 32 min

🧬 Quin Wills - Ochre Bio - Part 4 | Quin’s Journey Through Y Combinator | The Role of Empathy in Team Dynamics | Adapting in a Shifting Biotech Industry | Ochre Bio’s Fundraising Journey & Future Plans

13 juni 2024 | 22 min

🧬 Quin Wills - Ochre Bio - Part 3 | University of Oxford’s Single Cell Consortium | The Pitfalls of Californian Entrepreneurships | Dinner Table Origins of Ochre Bio | The Laws that Guide Ochre Bio

10 juni 2024 | 21 min

🧬 Quin Wills - Ochre Bio - Part 2 | Pursuing Dual Masters at Oxford & Cambridge | Moving from Genomics to RNA Research | Balancing Academia & Entrepreneurship | The Challenges of Product-Market Fit in Biotech

6 juni 2024 | 20 min

🧬 Quin Wills - Ochre Bio - Part 1 | Childhood Moments in Johannesburg | A Passion for Science Grows with an Evolving Society | Academic Experience in Biology and Genetics | Exposure to Bioinformatics and Big Data

3 juni 2024 | 19 min

🧬 Grant Aarons - FabricNano - Part 3 | Meeting His Co-Founder at Entrepreneur First | Importance of Sales to the Scientific Community | Disrupting the Petrochemical Industry | The Dark Horse of Biology, Synthetic Biology

29 maj 2024 | 34 min

🧬 Grant Aarons - FabricNano - Part 2 | The Defensibility of Software Companies | Studying Econometrics at London Business School | Joining Entrepreneur First | Becoming a Biotech Startup CEO & Navigating the Startup Journey

22 maj 2024 | 42 min

🧬 Grant Aarons - FabricNano - Part 1 | How NYC Shaped a Love of Engineering | Benefitting from Great Diversity at Cooper Union | Experiences & Opportunities at the Federal Reserve Bank of New York | Impact of the Economy on Deep Tech

15 maj 2024 | 38 min

🧬 Bryan Dechairo - Sherlock Biosciences - Part 3 | Assurex’s Journey From Garage to GeneSight | Keeping a Team Together Through the M&A Process | Building a Diagnostics Company During Covid | What Sherlock & Netflix Have in Common

8 maj 2024 | 50 min

🧬 Bryan Dechairo - Sherlock Biosciences - Part 2 | Transitioning From a Small Startup to Pfizer | Big Data's Role in Modern Genetics | Building & Leading Dynamic Teams | The Evolution of Personalized Medicine

1 maj 2024 | 34 min

🧬 Bryan Dechairo - Sherlock Biosciences - Part 1 | A Love of Science Blossoming from a 10-Acre Hobby Farm | Experiencing Great Diversity at UC Berkeley | Growth & Enjoyment of Startups | Unexpected Travels to Pursue a Dream Overseas

24 april 2024 | 33 min

🧬 Terry Lo - Vizgen - Part 3 | Transitioning to Vizgen From Akoya | What is Spatial Genomics | The Importance of Genetic Mapping | How to Grow Your Company During Turbulent Times

17 april 2024 | 30 min

🧬 Terry Lo - Vizgen - Part 2 | Terry’s Move from Big Pharma to Diagnostics | Introduction to Spatial Biology | Navigating Regulatory & Reimbursement Challenges in Diagnostics | Balancing Multiple Roles in M&A Negotiations

10 april 2024 | 30 min

🧬 Terry Lo - Vizgen - Part 1 | Leveraging Passion for Science to Succeed in Finance | Sales Excellence as an Introvert Through Competition | Financial Modeling & Creating Proper Deal Structure | How Not To Be A Jack of All Trades

3 april 2024 | 38 min

🧬 Mike Stadnisky - Thielsen Capital - Part 3 | Don’t Fake it ‘Til you Make It | Cleaning Your Corporate “Underwear” | Thielsen’s Investment Philosophy | The Critical Importance of Alignment

27 mars 2024 | 58 min

🧬 Mike Stadnisky - Thielsen Capital - Part 2 | Transitioning from Academia to Business | Breaking Into Business Development | Finding Decision Makers & Champions | Navigating Partnerships & Strategy

20 mars 2024 | 35 min

🧬 Mike Stadnisky - Thielsen Capital - Part 1 | Familial Exposure to Business & Science at a Young Age | The Importance of “Care Before You Share” | Actively Managing Your Time | A PhD is a 10,000 Hour Degree

13 mars 2024 | 51 min

🧬 Martin Brenner - iBio - Part 3 | Transitioning from Big Pharma to Biotech Startups | Lessons in Flexibility, Resilience, & Adaptability | Challenging Long-Held Beliefs in Drug Discovery | The Evolution & Future of iBio

6 mars 2024 | 81 min

🧬 Martin Brenner - iBio - Part 2 | Autonomy at Eli Lilly vs. Structure at Pfizer | Transitioning from AstraZeneca to Merck | Joys & Challenges When Relocating for Work | A Biotech Vision Leading to an Exit From Big Pharma

28 februari 2024 | 37 min

🧬 Martin Brenner - iBio - Part 1 | How Childhood Influences Shape Career Paths | Unexpected Crossovers Between Engineering & Veterinary Clinics | Eli Lilly Nurturing His Professional Development | Communication Can Make or Break Leadership

21 februari 2024 | 34 min

🧬 Jeff Kim - Slingshot Biosciences - Part 3 | Bucking the Status Quo | Raising Capital During Peak COVID | How To Find & Retain Great Talent | Building Partnerships with Distributors

14 februari 2024 | 29 min

🧬 Jeff Kim - Slingshot Biosciences - Part 2 | Working Toward One Goal In Industry | How Great Loss Prompted Professional Growth | Transitioning From a Basement Lab to a Thriving Company | A 6-Month Startup Idea Exceeding 12 Years of Operation

7 februari 2024 | 31 min

🧬 Jeff Kim - Slingshot Biosciences - Part 1 | Parental Freedom, Curiosity, & Self-Teaching | Music Accentuating a Passion for Science | The Benefits of Graduate Responsibilities as an Undergrad | Finding Fit & Balancing Research & the Arts

31 januari 2024 | 29 min

🧬 Stephanie Sirota - RTW Investments - Part 3 | The Emergence of Crossover Rounds | Building & Explaining Your Investment Thesis | Creating a .600 Batting Average Investment Fund | Transparency Between Investor & Founder | How to Get LPs to Say “Yes”

24 januari 2024 | 31 min

🧬 Stephanie Sirota - RTW Investments - Part 2 | Understanding Investment Banking’s Role in the Biosciences | Finding the Benefits of Your Uniqueness | Unexpected Pivots & Finding Passion in Your Work | Advice on Dealing with Bear Markets

17 januari 2024 | 33 min

🧬 Stephanie Sirota - RTW Investments - Part 1 | Early Influences on Leadership Style | Competitive Tennis Fosters Professional Drive | The Inverse Importance of Coaching | The Ending of a Dream to Open New Doors | Organically Choosing Your Track

10 januari 2024 | 24 min

🧬 Kittu Kolluri - Neotribe Ventures - Part 3 | Influence vs Control as a VC | Being a Leader in Venture vs a Leader in a Company | Starting Neotribe as a Passionate Rage Against the Status Quo | Sunk Cost vs Opportunity Cost | Optimizing Customer Acquisit

3 januari 2024 | 37 min

🧬 Kittu Kolluri - Neotribe Ventures - Part 2 | The Importance of Co-Authoring a Culture Statement | The Difference Between Leadership & Management | Raising Funds in Down-Market Conditions | The Value of Authenticity & Intellectual Curiosity

20 december 2023 | 32 min

🧬 Kittu Kolluri - Neotribe Ventures - Part 1 | Entrepreneurship as a First-Generation Immigrant | Working & Growing at Silicon Graphics | Learning From Mistakes & Pride of Ownership | The Dangers of Company Microcultures

13 december 2023 | 35 min

🧬 Fengru Lin - TurtleTree - Part 3 | The Value of Early HR for Company Building | Creating a People-First Work Culture | Refocusing to Reach Commercialization Sooner | Navigating Seed Series Fundraising

6 december 2023 | 29 min

🧬 Fengru Lin - TurtleTree - Part 2 | Salesforce’s Customer-Centric Sales Motion | The Value of Knowing Your Audience in Every Conversation | Why Executive Buy-In Matters | How a Hobby Led to TurtleTree’s Founding Idea

29 november 2023 | 24 min

🧬 Fengru Lin - TurtleTree - Part 1 | Growing Up in Hong Kong & Singapore | Serendipity & Its Effect on Career Paths | Connecting the Dots in Business | The Complex & Fragile World of Food Production | The Importance of QA/QC

22 november 2023 | 23 min

🧬 Sandy Paige - Seabright Ventures Fund - Part 4 | Creating Competitive Moats | Leveraging Financing Opportunities for Growth | The Purpose of a Board of Directors | Ambiguity as an Asset & Avoiding the Bias Toward Action

15 november 2023 | 29 min

🧬 Sandy Paige - Seabright Ventures Fund - Part 3 | Managing International Distribution | Meaningful Work & Personal Buy-In as a Form of Equity | Getting Into Business Development & The Importance of Sales Experience | Starting & Running a Search Fund

8 november 2023 | 24 min

🧬 Sandy Paige - Seabright Ventures Fund - Part 2 | Practicing Corporate Entrepreneurship | Life Lessons on How to Treat People | Seeking Margins & Avoiding Commodity | Scaling a Non-Profit | A CEO’s 3-5 Important Yearly Decisions

1 november 2023 | 36 min

🧬 Sandy Paige - Seabright Ventures Fund - Part 1 | The Value of Hustle & Being a Team Player | Saying Yes to Opportunities | Corporate Entrepreneurship & Finding Your Path | Entrepreneurs & Risk Aversion

25 oktober 2023 | 31 min

🧬 Maneesh Jain - Mirvie - Part 3 | Finding & Addressing Unmet Needs | The Maternal Health Crisis | Creating an Empathy-Focused Company Culture | Fundraising & Hitting Milestones in a Recession

18 oktober 2023 | 26 min

🧬 Maneesh Jain - Mirvie - Part 2 | Company Size & Innovation | Supply Chain Learnings from Other Industries | Scaling Go-to-Market Strategies | Culture’s Interaction with Mergers & Acquisitions

11 oktober 2023 | 29 min

🧬 Maneesh Jain - Mirvie - Part 1 | Fundamental Curiosity & The Value of Perseverance | Entrepreneurship for Societal Impact | “Magic Decades” & Finding Your Niche | The Importance of Scalability & Differentiation

4 oktober 2023 | 31 min

🧬 Alok Tayi - Vibe Bio - Part 3 | Biotech2050 Podcast Origins | Facilitating Innovation Conversations in Biotech | Vibe Bio’s Mission & Funding Cures Instead of Finding Them | Non-Linear Growth & Thinking Long Term

20 september 2023 | 27 min

🧬 Alok Tayi - Vibe Bio - Part 2 | Transitioning Into Entrepreneurship | The Importance of Sales Experience for Founders | The Power of a .edu Email | Managing Personnel During Hyperscaling

6 september 2023 | 27 min

🧬 Alok Tayi - Vibe Bio - Part 1 | Combining Software & Science | The Influence of Serendipity on Trajectory | The Critical Importance of Mentors | Working to Make an Impact & Solve Problems

23 augusti 2023 | 30 min

🧬 James Evans - PhenoVista - Part 3 | Being a Scrappy Founder | Adapting to Change & Learning to Pivot | The Importance of Professional Business Development | Setting Client Expectations

9 augusti 2023 | 19 min

🧬 James Evans - PhenoVista - Part 2 | Leaving Academia for Industry | How to Handle Miscommunication | Creating a Truly Diverse Company Culture | Being Bootstrapped & Forging a Business Model in the Real World

26 juli 2023 | 22 min

🧬 James Evans - PhenoVista - Part 1 | Skateboarding, Resilience, & Problem Solving | The Importance of Hands-On Lab Experiences | The Elegant Simplicity of Trial & Error | Running the Whitehead Institute’s Core Facility

12 juli 2023 | 28 min

🧬 Steve Visco - PolyPlus - Part 3 | Government Grants | The Importance of Storytelling for STEM Startups | Venture Capital vs Non-Dilutive Funding | How To Gain Strategic Corporate Interest Domestically & Abroad

28 juni 2023 | 37 min

🧬 Steve Visco - PolyPlus - Part 2 | Global Competition | Defending & Monetizing Your Intellectual Property | Dealing With Patent Trolls & Needing Multiple Patents Per Technology | The Importance of Global IP Strategy for Startups

14 juni 2023 | 34 min

🧬 Steve Visco - PolyPlus - Part 1 | Benefits of Strong Writing Skills for Entrepreneurs | Tech Transfer Process & Its Origins | Leveraging Your Expert Status in Negotiations to Gain Investment | Evaluating Personal Needs Alongside Professional Opportuniti

31 maj 2023 | 36 min

🧬 Jacob Glanville - Centivax - Part 4 | How to Choose the Right Venture Capital Partner | Fundraising as “Dating” | Finding Proper Alignment & The Win-Win | VC Network as a “Polishing Engine”

17 maj 2023 | 31 min

🧬 Jacob Glanville - Centivax - Part 3 | Building a Biotech without Venture Capital | Picking Lab Space & Company Growth | Equipment Leasing & Runway/Cash Flow Maximization | Process Drift & “The Respiration Model”

3 maj 2023 | 35 min

🧬 Jacob Glanville - Centivax - Part 2 | Creating Bioinformatic Tools | Innovation vs. Organization in Biotech Companies | Finding Excitement in Your Work | Tech Transfer & “Separation of Church and State”

18 april 2023 | 31 min

🧬 Jacob Glanville - Centivax - Part 1 | Hospitality Industry’s Applied Lessons | The Benefits of Contingency Planning & Fair Negotiation | How to Seek Translational Skill Sets & Cross Training

31 mars 2023 | 25 min

🧬 The Biotech Startups Podcast Trailer

7 december 2022 | 1 min

The Biotech Startups Podcast

Avsnitt

🧬 Non-Traditional Leadership & Knowledge Sharing: The New Edge in Biotech | Aaron Edwards (Part 3/4)

🧬 Why Most Biotech Startups Fail (And How to Survive Market Crashes) | Aaron Edwards (Part 2/4)

🧬 Embracing Identity & Curiosity: Being Different Fuels Innovation | Aaron Edwards (Part 1/4)

🧬 Growth Without Venture Capital: The Bootstrapped Bioscience Playbook | Ivan Liachko (Part 4/4)

🧬 How 3D Genome Mapping is Changing Everything We Know About DNA | Ivan Liachko (Part 3/4)

🧬 Startup Survival Skills: Resilience, Frugality & Real Talk in Biotech | Ivan Liachko (Part 2/4)

🧬 Passion Is Chaos: Grit, Curiosity, & the Biotech Breakthrough Mindset | Ivan Liachko (Part 1/4)

🧬 AI, Mentors & the Future of Biotech: Teambuilding, Investing, & Innovation | Johnny Hu (Part 4/4)

🧬 Biotech Investing Unlocked: Mindset Shift, Risk, and Founder-First Lessons | Johnny Hu (Part 3/4)

🧬 The Shelf Life of Innovation: CRISPR, Biotech Culture & Winning Teams | Johnny Hu (Part 2/4)

🧬 NASA, Harvard & Biotech: A Journey to Investing at Menlo Ventures | Johnny Hu (Part 1/4)

🧬 Simulating Life & Accelerating Discovery: Deep Origin’s Biotech Vision | Michael Antonov (Part 4/4)

🧬 Debugging Aging: How a VR Pioneer is Revolutionizing Longevity | Michael Antonov (Part 3/4)

🧬 Building Oculus: Innovation, Grit & the $2 Billion VR Revolution | Michael Antonov (Part 2/4)

🧬 The Borrowed Computer That Built Oculus - An Unlikely Biotech Journey | Michael Antonov (Part 1/4)

🧬 The Secret to Biotech Success: Time, Tools & Teamwork | Bogdan Knezevic (Part 4/4)

🧬 Purpose-Driven Innovation: Building Teams to Solve Biotech Problems | Bogdan Knezevic (Part 3/4)

🧬 Letting Go to Level Up: Oxford, Identity, & Tenacity in Biotech | Bogdan Knezevic (Part 2/4)

🧬Immigrant Grit & Athletic Discipline: Building a Biotech Legacy | Bogdan Knezevic (Part 1/4)

🧬 Redefining Biotech: Building Enduring Value Beyond Acquisition | Rabia Khan (Part 4/4)

🧬 Sales Skills & Resilience: Hidden Drivers of Biotech Success | Rabia Khan (Part 3/4)

🧬 Rabia Khan - Serna Bio: Bridging Science & Tech—PhDs, MBAs, & Biotech Innovation (Part 2/4)

🧬 Rabia Khan - Serna Bio: Unraveling the Genetics of AI-Driven Drug Discovery (Part 1/4)

🧬Alfredo Andere - LatchBio: Revolutionizing Biopharma Data & Mastering Enterprise Sales (Part 4/4)

🧬Alfredo Andere - LatchBio: Building Biotech Data Tools to Revolutionize Life Sciences (Part 3/4)

🧬Alfredo Andere - LatchBio: College Friends, Biotech Beginnings & Thoughtful Persistence (Part 2/4)

🧬 Alfredo Andere - LatchBio: Conquering Berkeley's EECS & Building a Global Vision (Part 1)

🧬 Michael Paliotti - MilliporeSigma: Master Biotech Sales & Build High-Performance Teams (Part 4/4)

🧬 Michael Paliotti: Blending Science, Sales, and Side Hustles in Biotech (Part 3/4)

🧬 Michael Paliotti: Navigating Biotech Careers & Building Lasting Relationships (Part 2/4)

🧬 Michael Paliotti: Navigating a Winding Path to Biotech Success (Part 1/4)

🧬 Stavros Papadopoulos: Transforming Data Management (Part 4/4)

🧬 Stavros Papadopoulos: Scaling TileDB & Revolutionizing Data Infrastructure (Part 3/4)

🧬Stavros Papadopoulos: How Serendipity Sparked TileDB's Startup Journey (Part 2/4)

🧬 Stavros Papadopoulos: A Journey in Computer Science & Data Management (Part 1/4)

🧬 Becky Beattie: Scaling LaunchBio & Democratizing Biotech Entrepreneurship (Part 2/2)

🧬 Becky Beattie: From Rural Beginnings to Building a National Biotech Network (Part 1)

🧬 Dr. Kate Yen: Scaling a Biotech, Running Lean, & Utilizing Translational Biology (Part 2)

🧬 Kate Yen - Part 1 | From Academia to Biotech Leader | Translating Research into Cancer Therapies | Early Days at Merck & Agios

🧬 Oguzhan Atay - Part 2 | From Immigrant to Biotech Innovator | Battling Deportation with Nobel Laureate Support | Building a $140M Prenatal Testing Empire

🧬 Oguzhan Atay - Part 1 | From Small-Town Turkey to Stanford PhD | Solving Cell Cycle Mysteries | Building a Biotech During a Global Pandemic

🧬 Parag Shah - Part 2 | Scaling a Multi-Billion Dollar Life Sciences Fund | Culture, Capital & Entrepreneurship | The K2 HealthVentures Story

🧬 Parag Shah - Part 1 | Rethinking Biotech Startup Funding | Building Smarter Capital Strategies | Risk, Reward & Leadership in Investing

🧬 Jason C. Foster - Part 2 | Manufacturing Brighter Futures | From Richmond to London: Building a Biotech Empire | Culture Eats Strategy for Breakfast

🧬 Jason C. Foster - Part 1 | From Paper Routes to Pharma | Navigating the Dot-Com Bubble | Building a $1B Addiction Medicine Business in 4 Years

🧬 Rafael Rosengarten - Part 4 | Lessons in Scaling a Biotech Startup | Using AI to Transform Cancer Diagnostics | The Genialis Supermodel & krasID

🧬 Rafael Rosengarten - Part 3 | Leveraging AI in Precision Medicine | How Predictive Biomarkers Transform Oncology | Lessons from Scaling a Startup

🧬 Rafael Rosengarten - Part 2 | From Marine Biology to Synthetic Biology | Building Biofuel Tools at JBEI | When Academic Labs Embrace Entrepreneurship

🧬 Rafael Rosengarten - Part 1 | From Salt Marsh to Biotech CEO | Snorkeling into Science | Choosing Marine Biology Over Cooking on a Mediterranean Yacht

🧬 Cyriac Roeding - Part 4 | Revolutionizing Cancer Detection & Therapy | Harnessing Synthetic Biology to Reshape Diagnostics | Solving Biotech’s Toughest Problems

🧬Cyriac Roeding - Part 3 | Founding Shopkick During the 2008 Financial Crisis | Transforming Retail with Mobile Tech | Exploring AI’s Use in Clinical Trials & Reshaping Drug Development

🧬 Cyriac Roeding - Part 2 | From Digital Clocks to Global Mobile Marketing | Cracking Coca-Cola's 160 Million Bottle Code | Silicon Valley's Pine-Scented Entrepreneurship | Leapfrogging Technology in the Amazon Jungle

🧬 Cyriac Roeding - Part 1 | From Flea Market Entrepreneur to Silicon Valley CEO | Reinvention During an Exchange Year | Finding Perspective in Japanese Business Culture

🧬 Kate Neville - Part 4 | Balancing IP Enforcement & Licensing | Leveraging Shelved Pharma Assets | Building Resilient IP Portfolios

🧬Kate Neville - Part 3 | Fundamentals of IP Strategy for Biotechs | Safeguarding Discoveries & Technology | Aligning Science with Patents | Navigating Global Patent Considerations

🧬Kate Neville - Part 2 | Navigating Law School as a Scientist | From Patent Agent to Lawyer | Thriving at the Intersection of Science & Law | Continuous Learning in Diverse Scientific Fields

🧬 Kate Neville - Part 1 | From Youngest of Six to Patent Law Pioneer | When Chemistry Sets Spark Scientific Careers | Leading Through Autonomy | Serendipitous Path from Lab Bench to IP Law

🧬 Barry Ticho - Part 4 | Founding Verve Therapeutics Over Breakfast | Gene Editing for Cardiovascular Disease | Leadership Lessons From a First-Time Founder | Stoke’s Vision for RNA-Based Medicines

🧬 Barry Ticho - Part 3 | Lessons From Rigorous Drug Development | Industry vs. Academic Research Standards | A Patient-Centered Approach to Clinical Trials | How RNA is Shaping Modern Medicine

🧬Barry Ticho - Part 2 | Zebrafish Hearts & Pediatric Cardiology | Balancing Lab Work & Clinical Practice | Navigating Academic Medicine's Challenges | The Draw of Biopharma & Translational Medicine

🧬Barry Ticho - Stoke Therapeutics - Part 1 | From Family of Physicians to Vision-Driven Scientist | Barry’s MD-PhD Journey | Leadership Through Critical Thinking & Resilience | The Journey From Academia to Industry

🧬Chris Moxham - Transcripta Bio - Part 4 | Partnership Strategies with Big Pharma | Balancing Science & Business | Leveraging AI in Drug Discovery | The Vision for Transcripta Bio

🧬Chris Moxham - Transcripta Bio - Part 3 | Embracing the Startup Challenge | Mastering Science-to-Business Communication | Building a Scalable Discovery Engine | Leveraging AI & Genetics in Drug Development

🧬Chris Moxham - Transcripta Bio - Part 2 | From Eli Lilly Recruit to NYC Lab Builder | Leading High-Stakes Drug Discovery | Pioneering Quantitative Biology | "Making the Trains Run on Time"

🧬Chris Moxham - Transcripta Bio - Part 1 | From Long Island to Biotech Pioneer | Cornell's Pivotal Role in Research Passion | Strategic Leap to Pharma Industry | Cultivating Effective Leadership in Science

🧬Michael Chen - Nuclera - Part 2 | From Grad Student to Biotech CEO | Unique Challenges Combining Science & Business | Developing Breakthrough Products | Building Partnerships with Big Pharma | Creating a Biotech GTM Strategy

🧬Michael Chen - Nuclera - Part 1 | Influence of a Data-Driven Family | Do the Dishes in a Lab | NIH-Oxford Cambridge Scholarship Program | What Got Us Here Won’t Get Us There

🧬 Neela Patel - Bonum Therapeutics - Part 4 | Transitioning to Seattle Genetics & Business Development | Insights from Roche’s Acquisition | Building a Transformative Oncology Pipeline with Bonum Therapeutics

🧬 Neela Patel - Bonum Therapeutics - Part 3 | Developing Pipeline Strategy at Poniard Pharmaceuticals | Business & Corporate Development in Oncology | Transitioning from Abbott to AbbVie to Seagen

🧬Neela Patel - Bonum Therapeutics - Part 2 | Leading an Academic Microbiology Lab | The Value of Personal Relationships in the Workplace | Leading a Team & Learning on the Job | The Volatility of an Acquisition

🧬 Neela Patel - Bonum Therapeutics - Part 1 | Growing Up in an Intellectual Household | How One Biology Class Inspired Her | Working With Influential Scientists at DNAX | Pursuing the Intersection of Science & Business

🧬eMalick Njie, Ph.D - Ecotone - Part 4 | Building Ecotone AI to Cure Rare Diseases | Diffusion Transformers in Genomics | Synthetic Genomes for AI Training | Long-Term Vision for Genetic Breakthroughs

🧬 eMalick Njie, Ph.D - Ecotone - Part 3 | Founding an AI-Powered Biotech | Overcoming Challenges & Personal Sacrifices | Importance of Team Alignment | Combining AI, Genetics, & Population Studies

🧬eMalick Njie, Ph.D - Ecotone - Part 2 | What is Memory? | Playing “Stump the Professor” | Lab Coat Labs vs Sandals Labs | Wanting to Help People at Scale

🧬eMalick Njie, Ph.D - Ecotone - Part 1 | Growing Up in the Gambia | The Unending Book of Neuroscience | Being a Professional Scientist | How to Lose Your MIT Recommendation Letter: 101

🧬Barbara Alcaraz Silva - J.P. Morgan - Part 4 | Barbara’s Pivot into Banking | The Power of Mentorship & Resilience | Seizing Unexpected Opportunities | The Challenges of Building a Career in Science & Finance

🧬 Barbara Alcaraz Silva - J.P. Morgan - Part 3 | From Academia to Entrepreneurship, Investing, & Advising | Co-Founding a Startup | Challenges of Early-Stage Company Building | Improve Your Investor Pitch & Connect with the Right People

🧬 Barbara Alcaraz Silva - J.P. Morgan - Part 2 | Mentorship & Research at the Beckman Laser Institute | An Entrepreneurial PhD Experience | Exploring Stem Cell Biology in London | Navigating Networking & Postdoc Opportunities